Here’s How Your Returns Would Look if You Had Invested in Aphria (TSX:APHA) When Pot Was Legalized

Aphria Inc (TSX:APHA)(NYSE:APHA) got a big boost this month after posting a strong quarter, but would it have been a good investment to make when pot was legalized?

Cannabis has undoubtedly been the hottest industry over the past couple of years. We’ve seen some soaring valuations and companies trade at ridiculous multiples of their sales. Even significant cash burn and mounting losses haven’t been able to keep investors away.

Recently, however, we have seen more bearish activity in the industry and valuations have started to come down, but not nearly enough to wipe away the growth that some stocks have achieved.

Earlier this month, we saw Aphria Inc (TSX:APHA)(NYSE:APHA) jump in value after it posted a profit and got investors excited about the possibility of a marijuana company actually not being in the red.

After all, it’s not a sight that we’ve seen very often, as normally cannabis companies are mounting losses and that hasn’t always gone over very well, especially when it brings down the earnings of a big investor.

How Aphria has done this past year

Aphria typically hasn’t been one of the strongest performing cannabis stocks, normally lagging behind the industry leaders. If we ignore the recent bump up in price that the company got from its earnings result, then through the first seven months of the year,

Aphria’s share price has actually fallen by about 9%. The stock was doing well until about April when a disappointing quarter sent the stock over a cliff.

However, let’s take a look back even further, to when marijuana was legalized, on October 17, 2018. Here’s how your returns would have looked if you had invested on that day:

APHA Chart

It’s a dark reality of how bearish investors have been on pot stocks since then. No longer are promises of future growth and potential enough to get investors excited about cannabis.

Even with the legalization of edibles around the corner, it hasn’t been enough to give prices a boost. If we extend the returns to the end of last week and include the boost that Aphria received from earnings, it’s still nowhere near enough to make up for the losses since legalization:

APHA Chart

Takeaways for investors

There are a couple of important takeaways from this.

The first is that leading up into legalization we saw cannabis stocks soaring even though the bullishness may not have been warranted, making the shares significantly overpriced.

Many of those investors likely sold off their shares with legalization having come and gone, knowing full well that reality had arrived and that it was time for companies to start performing and measuring them against the sky-high growth many expected for the industry.

It was a tall task — one that investors likely knew wasn’t going to happen. It’s an important reminder that hype alone can’t make a stock a good investment.

Another important takeaway is that as quickly as pot stocks soared, they have crashed just as quickly. Most of the losses that Aphria incurred since October took place in just the first few months after legalization.

With cannabis stocks still looking pretty expensive today, there may be another wave of sell-offs still to come.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »